Afinitor (Everolimus) Approved For Renal Angiomyolipomas By FDAMedical News TodayAfinitor (everolimus) has been approved by the FDA for renal angiomyolipomas (non-cancerous kidney tumors) that do not require urgent surgery in patients with TSC (tuberou…
TribLocalScience Connections: Bioengineered Organs May Hold the Future for TransplantsTribLocalExamples of medicine prescribed include Tacrolimus or Thymoglobulin. For kidney and liver transplants, there is a current success rate of about 90 percent. Q…
Excessive Neutropenia for Weekly Everolimus + DocetaxelDoctors LoungeFor patients with metastatic breast cancer, weekly treatment with everolimus plus docetaxel every three weeks results in dose-limiting neutropenia and variable clearance of both drugs…
Afinitor Approved for Non-cancerous Kidney TumorsKansas City infoZineWashington, DC – infoZine – The US Food and Drug Administration today approved Afinitor (everolimus), the first drug approved specifically to treat non-cancerous kidney tumors (renal …
Life Of Riley: Choosing To Try Though Nothing Else Has WorkedWBURAnd the drug it offered, sirolimus, (pronounced seer-o-LI-mus), though not brand new, was just beginning to be tested for this new purpose. 'I really want to be hopeful about this tri…
Moneycontrol.comCRISIL revises Panacea Biotec`s fundamental grade to 2/5Moneycontrol.comIts existing formulations such as Tacrolimus and Cyclosporine continue to gain traction in the overseas market. It has also launched new formulations in different t…
Foamix Obtains US Patent "Waterless Hydrophilic Foam" for Dermatological and …PR.com (press release)… covers a platform of versatile polyethylene glycol-based foam formulations, which can carry a variety of dermatological and gynecologica…
FDA Approves Novartis's Afinitor Tablets To Treat Patients With Kidney TumorsNASDAQ(RTTNews.com) – Novartis Pharmaceuticals Corp., an affiliate of Novartis AG (NVS), announced today that the US Food and Drug Administration approved Afinitor (everol…
FDA approves Novartis Afinitor to treat kidney tumorsPharmaceutical Business ReviewThe US Food and Drug Administration (FDA) has approved Novartis Afinitor (everolimus) to treat patients with non-cancerous kidney tumors associated with tuberous scleros…
FDA Approves Everolimus for Renal AngiomyolipomasMedscapeApril 26, 2012 — The US Food and Drug Administration has approved everolimus (Afinitor) for the treatment of renal angiomyolipomas not requiring immediate surgery, in patients with tuberous scl…